A Cross Sectional Study to Assess Liver Fibrosis in Patients with Diabetes and Metabolic Syndrome in India

Dr. Mohammed Ibrahim

Authors

Dr. Mohammed Ibrahim

Keywords:

liver fibrosis, enhanced liver fibrosis, non alcoholic fatty liver disease, cirrhosis, NAFLD fibrosis score

Abstract

Abstract not found

Downloads

How to Cite

A Cross Sectional Study to Assess Liver Fibrosis in Patients with Diabetes and Metabolic Syndrome in India. (2016). Global Journal of Medical Research, 16(K5), 17-22. https://medicalresearchjournal.org/index.php/GJMR/article/view/1165

Download Citation

References

S Friedman (2003) Liver fibrosis -from bench to bedside. 38(1), 38-S53.

I Wanless (2004) Pathogenesis of cirrhosis. 19, 369-371.

E Brunt (2004) Nonalcoholic steatohepatitis. 24, 3-20.

Ramón Bataller, Kari North, David Brenner (2003) Genetic Polymorphisms and the Progression of Liver Fibrosis: A Critical Appraisal. 37(3), 493-503.

Maurizio Parola, Gaia Robino (2001) Oxidative stress-related molecules and liver fibrosis. 35(2), 297-306.

Virginia Hernandez-Gea, Scott Friedman (2011) Pathogenesis of Liver Fibrosis. 6(1), 425-456.

R Bataller, A Brenner, Liver, Fibrosis (2005) Unknown Title. 115, 209-218.

N Afdhal (2003) Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests?. 37, 972-974.

Qingsong Xie, Xiaohu Zhou, Pengfei Huang, Jianfeng Wei, Weilin Wang, Shusen Zheng (2014) The Performance of Enhanced Liver Fibrosis (ELF) Test for the Staging of Liver Fibrosis: A Meta-Analysis. 9(4), e92772.

Ralf Lichtinghagen, Daniel Pietsch, Heike Bantel, Michael Manns, Korbinian Brand, Matthias Bahr (2013) The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values. 59(2), 236-242.

I Hind, Fallatah (2014) Noninvasive Biomarkers of Liver Fibrosis: An Overview. 2014, 15.

Chun-Tao Wai, Joel Greenson, Robert Fontana, John Kalbfleisch, Jorge Marrero, Hari Conjeevaram, Null- Lok (2003) A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C. 38(2), 518-526.

Anaïs Vallet-Pichard, Vincent Mallet, Bertrand Nalpas, Virginie Verkarre, Antoine Nalpas, Valérie Dhalluin-Venier, Hélène Fontaine, Stanislas Pol (2007) FIB-4. 46(1), 32-36.

Masahiko Koda, Yoshiko Matunaga, Manri Kawakami, Yukihiro Kishimoto, Takeaki Suou, Yoshikazu Murawaki (2007) Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. 45(2), 297-306.

V Mohan (2009) Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.

Deepak Amarapurkar, Estsuko Hashimoto, Laurentius Lesmana, José Sollano, Pei‐jer Chen, Khean‐lee Goh (2007) How common is non‐alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?. 22(6), 788-793.

S Grundy, J Cleeman, S Daniels, K Donato, R Eckel, B Franklin (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. 112(17), 2735-2752.

Ajay Duseja, Ashim Das, Reena Das, R Dhiman, Y Chawla, A Bhansali, Naveen Kalra (2007) The Clinicopathological Profile of Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD) is Different from That in the West. 52(9), 2368-2374.

Paul Angulo, Jason Hui, Giulio Marchesini, Ellisabetta Bugianesi, Jacob George, Geoffrey Farrell, Felicity Enders, Sushma Saksena, Alastair Burt, John Bida, Keith Lindor, Schuyler Sanderson, Marco Lenzi, Leon Adams, James Kench, Terry Therneau, Christopher Day (2007) The NAFLD fibrosis score. 45(4), 846-854.

Laurent Castera, Massimo Pinzani (2010) Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?. 59(7), 861-866.

J Dowman, J Tomlinson, P Newsome (2011) Systematic review: the diagnosis and staging of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis. 33(5), 525-540.

E Gómez-Domínguez, J Mendoza, S Rubio, J Moreno-Monteagudo, L García-Buey, R Moreno-Otero (2006) Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. 24, 513-518.

Zhiqiao Zhang, Gongsui Wang, Kaifu Kang, Guobiao Wu, Peng Wang (2016) The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection. 11(4), e0152757.

Karel Dvorak, Jan Stritesky, Jaromir Petrtyl, Libor Vitek, Renata Sroubkova, Martin Lenicek, Vaclav Smid, Martin Haluzik, Radan Bruha (2014) Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study. 9(10), e111551.

V Papastergiou, E Tsochatzis, A Burroughs (2012) Noninvasive assessment of liver fibrosis. 25(3), 218-231.

S Kalra, M Vithalani, G Gulati, C Kulkarni, Y Kadam, J Pallivathukkal (2013) Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). 61, 448-453.

Halina Cichoż-Lach, A Michalak (2014) Oxidative stress as a crucial factor in liver diseases. 20(25), 8082.

Hussein Atta (2015) Reversibility and heritability of liver fibrosis: Implications for research and therapy. 21(17), 5138.